Many pediatric cancers are fundamentally developmental disorders. With our recent publication we have discovered the origins of medulloblastoma within the developing cerebellum. #teamscience#stjude
https://t.co/xf7feR0iD9
The Northcott lab conducted an extensive re-analysis of a single-cell transcriptional atlas of human cerebellar development originally published in 2022. During this process, we identified significant concerns related to data integrity and interpretation,
These findings set the foundation to better model and hopefully treat these tumors going forward. So proud to be a part of this all-star team with Laure Bihannic and @B_gudenas headed by @drpaulnorthcott and @neurodevKathy
Many pediatric cancers are fundamentally developmental disorders. With our recent publication we have discovered the origins of medulloblastoma within the developing cerebellum. #teamscience#stjude
https://t.co/xf7feR0iD9
These cells are located in a region of the cerebellum known as the Rhombic Lip, which give rise to the glutamatergic neurons. Overlapping MRIs of many Group 3 and 4 medulloblastoma tumors revealed that these tumors are fully encapsulated within this region.
St. Jude scientists have discovered the developmental origins for Group 3 and Group 4 medulloblastoma which may help improve research models and potential therapeutics. https://t.co/YxW7LFyQ8k @nature @drpaulnorthcott #childhoodcancer#CCAM
1/5 Our new paper resolving the developmental origins of Group-3 Medulloblastoma is out @Nature
Previously the cellular origins of Group3-MB were unknown despite multiple cross-species efforts comparing MB tumors to mouse cerebellar single-cell atlases.
https://t.co/7RpPowpO7d
@lab_ogden @cshperspectives For software developers it is common to have a small rubber duck to talk to when debugging a program. Sounds like this might work well for complaining about reviewers as well
Excited to share our latest pre-print building a single-nucleus atlas of pediatric rhabdomyosarcoma. We report heterogeneity within 18 patient tumors, and 18 xenografts from those same patient tissues, and show treatment selects for mesoderm-like cells #sarcoma@StJudeResearch